HRH3
Basic information
Region (hg38): 20:62214960-62220278
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HRH3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 20 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 3 | 2 |
Variants in HRH3
This is a list of pathogenic ClinVar variants found in the HRH3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-62216129-C-T | Benign/Likely benign (Oct 01, 2023) | |||
20-62216190-T-C | not specified | Uncertain significance (Jan 16, 2024) | ||
20-62216312-G-A | Benign (Apr 10, 2018) | |||
20-62216338-G-A | not specified | Uncertain significance (Jan 27, 2022) | ||
20-62216362-C-A | not specified | Uncertain significance (Dec 09, 2023) | ||
20-62216409-C-T | not specified | Uncertain significance (May 17, 2023) | ||
20-62216422-C-T | not specified | Uncertain significance (Jan 20, 2023) | ||
20-62216430-G-A | not specified | Uncertain significance (May 31, 2023) | ||
20-62216433-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
20-62216470-C-T | not specified | Uncertain significance (Sep 15, 2021) | ||
20-62216487-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
20-62216493-G-A | not specified | Uncertain significance (Feb 01, 2023) | ||
20-62216546-G-A | Likely benign (Nov 01, 2023) | |||
20-62216574-C-G | not specified | Uncertain significance (Dec 14, 2023) | ||
20-62216605-C-T | not specified | Uncertain significance (Jan 11, 2023) | ||
20-62216613-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
20-62216634-C-T | not specified | Uncertain significance (Oct 19, 2024) | ||
20-62216638-C-A | not specified | Uncertain significance (Jun 29, 2023) | ||
20-62216650-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
20-62216704-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
20-62216742-G-A | not specified | Uncertain significance (May 10, 2022) | ||
20-62216884-G-A | not specified | Uncertain significance (Jun 04, 2024) | ||
20-62216898-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
20-62218602-G-A | Likely benign (Feb 01, 2023) | |||
20-62219725-G-A | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HRH3 | protein_coding | protein_coding | ENST00000340177 | 3 | 5298 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0408 | 0.953 | 125362 | 0 | 5 | 125367 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.27 | 169 | 275 | 0.614 | 0.0000180 | 2791 |
Missense in Polyphen | 61 | 103.96 | 0.58674 | 1004 | ||
Synonymous | 0.238 | 125 | 128 | 0.973 | 0.00000839 | 992 |
Loss of Function | 2.42 | 5 | 15.2 | 0.330 | 7.50e-7 | 144 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000284 | 0.0000265 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: The H3 subclass of histamine receptors could mediate the histamine signals in CNS and peripheral nervous system. Signals through the inhibition of adenylate cyclase and displays high constitutive activity (spontaneous activity in the absence of agonist). Agonist stimulation of isoform 3 neither modified adenylate cyclase activity nor induced intracellular calcium mobilization.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class A Rhodopsin-like;Monoamine Transport;Signaling by GPCR;Signal Transduction;Histamine receptors;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- loftool
- 0.163
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.69
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- Y
- hipred_score
- 0.735
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.916
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hrh3
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- hrh3
- Affected structure
- sleep
- Phenotype tag
- abnormal
- Phenotype quality
- behavioral quality of a process
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway;chemical synaptic transmission;neurotransmitter secretion;negative regulation of glutamate secretion;regulation of norepinephrine secretion;negative regulation of serotonin secretion;cognition;G protein-coupled serotonin receptor signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;dendrite;presynapse
- Molecular function
- G protein-coupled receptor activity;histamine receptor activity;G protein-coupled serotonin receptor activity;G protein-coupled acetylcholine receptor activity;neurotransmitter receptor activity